Literature DB >> 27786539

Short-chain fatty acids in control of energy metabolism.

Jiamiao Hu1,2, Shaoling Lin1, Baodong Zheng1, Peter C K Cheung3.   

Abstract

Short-chain fatty acids (SCFAs), especially acetate, propionate and butyrate, are the end products from the intestinal microbial fermentation of dietary fibers and resistant starch. It has been well documented that plasma and colonic SCFAs are associated with metabolic syndromes. Recently, the involvement of SCFAs in energy homeostasis regulation has been extensively studied. The importance of SCFAs on energy metabolism has highlighted the potential of modulating SCFAs as a nutritional target to prevent and counteract metabolism disorders and its associated diseases such as obesity and type 2 diabetes. Here, we summarize the current knowledge about the biological properties of SCFAs with their impact on the energy homeostasis.

Entities:  

Keywords:  GPR41/43; Short-chain fatty acids; energy homeostasis; gut health

Mesh:

Substances:

Year:  2017        PMID: 27786539     DOI: 10.1080/10408398.2016.1245650

Source DB:  PubMed          Journal:  Crit Rev Food Sci Nutr        ISSN: 1040-8398            Impact factor:   11.176


  59 in total

1.  A High-Carbohydrate, High-Fiber, Low-Fat Diet Results in Weight Loss among Adults at High Risk of Type 2 Diabetes.

Authors:  Allison C Sylvetsky; Sharon L Edelstein; Geoffrey Walford; Edward J Boyko; Edward S Horton; Uzoma N Ibebuogu; William C Knowler; Maria G Montez; Marinella Temprosa; Mary Hoskin; Kristina I Rother; Linda M Delahanty
Journal:  J Nutr       Date:  2017-09-27       Impact factor: 4.798

Review 2.  The association between dietary fibre deficiency and high-income lifestyle-associated diseases: Burkitt's hypothesis revisited.

Authors:  Stephen J O'Keefe
Journal:  Lancet Gastroenterol Hepatol       Date:  2019-12

3.  Impaired butyrate absorption in the proximal colon, low serum butyrate and diminished central effects of butyrate on blood pressure in spontaneously hypertensive rats.

Authors:  Tao Yang; Kacy L Magee; Luis M Colon-Perez; Riley Larkin; Yan-Shin Liao; Eliza Balazic; Jonathan R Cowart; Rebeca Arocha; Ty Redler; Marcelo Febo; Thomas Vickroy; Christopher J Martyniuk; Leah R Reznikov; Jasenka Zubcevic
Journal:  Acta Physiol (Oxf)       Date:  2019-02-20       Impact factor: 6.311

4.  CX3CR1 regulates gut microbiota and metabolism. A risk factor of type 2 diabetes.

Authors:  Celine Pomié; Florence Servant; Lucile Garidou; Vincent Azalbert; Aurélie Waget; Pascale Klopp; Céline Garret; Julie Charpentier; Francois Briand; Thierry Sulpice; Benjamin Lelouvier; Victorine Douin-Echinard; Rémy Burcelin
Journal:  Acta Diabetol       Date:  2021-03-22       Impact factor: 4.280

Review 5.  An important link between the gut microbiota and the circadian rhythm: imply for treatments of circadian rhythm sleep disorder.

Authors:  Yufei Tian; Wei Yang; Gang Chen; Chuanlong Men; Yifan Gu; Xiaoran Song; Ruilin Zhang; Laiyou Wang; Xin Zhang
Journal:  Food Sci Biotechnol       Date:  2022-01-18       Impact factor: 2.391

6.  Changes in Serum Fatty Acid Composition and Metabolome-Microbiome Responses of Heigai Pigs Induced by Dietary N-6/n-3 Polyunsaturated Fatty Acid Ratio.

Authors:  Liyi Wang; Qiuyun Nong; Yanbing Zhou; Ye Sun; Wentao Chen; Jintang Xie; Xiaodong Zhu; Tizhong Shan
Journal:  Front Microbiol       Date:  2022-06-22       Impact factor: 6.064

7.  The Difference of Gut Microbiota and Their Correlations With Urinary Organic Acids Between Autistic Children With and Without Atopic Dermatitis.

Authors:  Ru-Ping Hong; Yue-Ying Hou; Xin-Jie Xu; Ji-Dong Lang; Yun-Feng Jin; Xiao-Feng Zeng; Xuan Zhang; Geng Tian; Xin You
Journal:  Front Cell Infect Microbiol       Date:  2022-06-21       Impact factor: 6.073

8.  Analysis of Intestinal Short-Chain Fatty Acid Metabolism Profile After Probiotics and GLP-1 Treatment for Type 2 Diabetes Mellitus.

Authors:  Qiuxia Min; Yan Wang; TaiCheng Jin; Lei Zhu; XianYan Wu; YiKun Li; YanJiao Wang; Ning Xu
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-30       Impact factor: 6.055

Review 9.  Gut microbiota-derived metabolites as central regulators in metabolic disorders.

Authors:  Allison Agus; Karine Clément; Harry Sokol
Journal:  Gut       Date:  2020-12-03       Impact factor: 23.059

Review 10.  Multi-Pharmacology of Berberine in Atherosclerosis and Metabolic Diseases: Potential Contribution of Gut Microbiota.

Authors:  Shengjie Yang; Dan Li; Zongliang Yu; Yujuan Li; Min Wu
Journal:  Front Pharmacol       Date:  2021-07-09       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.